Volume 29, Number 8—August 2023
Dispatch
Uniting for Ukraine Tuberculosis Screening Experience, San Francisco, California, USA
Janice K. Louie
, Rocio Agraz-Lara, Laura Romo, Cristy Dieterich, Cathleen Xing, and Susannah Graves
, Rocio Agraz-Lara, Laura Romo, Cristy Dieterich, Cathleen Xing, and Susannah Graves
Table
Characteristics of 299 parolees from Ukraine screened for tuberculosis, San Francisco, California, USA, May 2022‒April 2023*
| Characteristic |
Value |
| Sex | |
| F | 183 (61.2) |
| M |
116 (38.8) |
| Median age, y (range) |
33 (0.75–84) |
| TB medical risk factor per patient report | |
| Diabetes mellitus | 3/299 (1.0) |
| HIV infection | 0/299 (0.0) |
| Alcohol or substance use | 0/299 (0.0) |
| Other† |
0/299 (0.0) |
| Positive HIV test result‡ | 0/274 (0.0) |
| Positive IGRA result | 22/299 (7.4) |
| Median age, y (range) with positive IGRA result |
51.5 (17–81) |
| Chest radiograph performed§ | 240/245 (98.0) |
| Abnormalities on chest radiograph, all | 7/240 (2.9) |
| Median age, y (range) with abnormal chest radiograph | 43 (36–63) |
| Abnormalities on chest radiograph, IGRA negative |
4/240 (1.7) |
| Diagnosis of active TB |
1/299 (0.33) |
| LTBI treatment recommended | |
| Received treatment for LTBI/IGRA positive result | 14/22 (63.6) |
| Not treated for LTBI/IGRA positive result | 8/22 (36.4) |
| Refused treatment | 5/22 (22.7) |
| Pending start of LTBI treatment | 3/22 (13.6) |
*Values are no. (%) or no. positive/no. tested (%) except as indicated. IGRA, interferon-γ-release assay; LTBI, latent TB infection; TB, tuberculosis.†Other medical TB risk factors: severe kidney disease, silicosis, low bodyweight, organ transplant, head and neck cancer, and treatment with immunosuppressive agents (10). ‡All 298 parolees >2 years of age were offered HIV testing; 274 (91.9%) agreed. §All 245 parolees ≥15 y of age were offered chest radiograph screening; 240 (98.0%) agreed.
References
- Dahl V, Migliori GB, Lange C, Wejse C. War in Ukraine: an immense threat to the fight against tuberculosis. Eur Respir J. 2022;59:
2200493 . DOIPubMedGoogle Scholar - European Centre for Disease Prevention and Control (ECDC)/World Health Organization Regional Office for Europe (WHO Europe). Tuberculosis surveillance and monitoring in Europe, 2022–2020 data. Copenhagen: WHO Regional Office for Europe and Stockholm/ECDC; 2022 [cited 2023 Jun 14]. https://www.ecdc.europa.eu/sites/default/files/documents/Tuberculosis-surveillance-monitoring-europe-2022_0.pdf
- World Health Organization. Global tuberculosis report 2022. 2022 [cited 2024 Jun 14]. https://www.who.int/publications/i/item/9789240061729
- Centers for Disease Control and Prevention. Dear colleague letters: Uniting for Ukraine program, June 21, 2022 [cited 2023 Jun 14]. https://www.cdc.gov/tb/publications/letters/2022/unitingforukraine-DCL.html
- US Citizenship and Immigration Services. Uniting for Ukraine vaccine attestation [cited 2023 Jun 14]. https://www.uscis.gov/humanitarian/uniting-for-ukraine/uniting-for-ukraine-vaccine-attestation
- California Department of Public Health Office of Refugee Health. Program overview [cited 2023 Jun 14]. https://www.cdph.ca.gov/Programs/CID/ORH/Pages/Program%20Overview.aspx
- San Francisco Department of Public Health Newcomers Health Program. Our programs [cited 2023 Jun 14]. https://zuckerbergsanfranciscogeneral.org/patient-visitor-resources/refugee-services
- Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A, et al. Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020;69(no. RR-1):1–11. DOIPubMedGoogle Scholar
- Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, et al. Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2019;200:e93–142. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. TB risk factors. 2016 [cited 2023 Jun 14]. https://www.cdc.gov/tb/topic/basics/risk.html
- Dahl VN, Tiberi S, Goletti D, Wejse C. Armed conflict and human displacement may lead to an increase in the burden of tuberculosis in Europe. Int J Infect Dis. 2022;124(Suppl 1):S104–6. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Tuberculosis technical instructions for panel physicians [cited 2023 Jun 14]. https://www.cdc.gov/immigrantrefugeehealth/panel-physicians/tuberculosis.html
- Centers for Disease Control and Prevention. Immigrant, refugee, and migrant health. Guidance for screening for tuberculosis infection and disease during the domestic medical examination for newly arrived refugees [cited 2023 Jun 14]. https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/tuberculosis-guidelines.html
- Yamasue M, Komiya K, Usagawa Y, Umeki K, Nureki SI, Ando M, et al. Factors associated with false negative interferon-γ release assay results in patients with tuberculosis: A systematic review with meta-analysis. Sci Rep. 2020;10:1607. DOIPubMedGoogle Scholar
- US Citizenship and Immigration Services. Processes for Cubans, Haitians, Nicaraguans and Venezuelans [cited 2023 Jun14]. https://www.uscis.gov/sites/default/files/document/flyers/Process-for-Cubans-Haitians-Nicaraguans-and-Venezuelans-Flyer.pdf
Page created: June 14, 2023
Page updated: July 20, 2023
Page reviewed: July 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.